Cyclacel Pharmaceuticals, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2010 to 2022

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2010 to 2022.
  • Cyclacel Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 12.6M shares, a 23.8% increase year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 11.3M shares, a 26.1% increase from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 8.93M shares, a 146% increase from 2020.
  • Cyclacel Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 3.63M shares.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 11.3M +2.33M +26.1% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-08
2021 8.93M +5.29M +146% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 3.63M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2013 15.2M +6.87M +82.8% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-26
2012 8.29M +1.11M +15.4% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-26
2011 7.19M +1.78M +32.9% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-26
2010 5.41M Jan 1, 2010 Dec 31, 2010 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.